Psychedelics Law Reformers Hit Multiple Setbacks In 2024
By Sam Reisman
In 2024, advocates, physicians and researchers attempted to broaden lawful access to federally illegal psychedelic drugs through a variety of avenues — the new drug approval process, litigation and a ballot initiative — with the upshot that the law remains largely unchanged and, for the most part, still restricts legal use and possession of these substances.
Read full article »
| Save to favorites »
Analysis
The Most Significant Trade Secrets Cases Of 2024
By Ivan Moreno
Insulet Corp. became the latest company to notch a colossal trade secrets award, and a new presidential administration has attorneys wondering what will become of the Federal Trade Commission's pending proposal to ban employee noncompete agreements. Here's a look at trade secrets cases that defined 2024 and what to expect from the FTC in the coming year.
Read full article »
| Save to favorites »
POLICY & REGULATION
LITIGATION
DEALS
EXPERT ANALYSIS
LEGAL INDUSTRY
|